These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21518947)

  • 1. Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
    Simon JA
    Arch Intern Med; 2011 Apr; 171(8):777-8. PubMed ID: 21518947
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
    Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
    Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
    Cinciripini PM; Robinson JD; Karam-Hage M; Minnix JA; Lam C; Versace F; Brown VL; Engelmann JM; Wetter DW
    JAMA Psychiatry; 2013 May; 70(5):522-33. PubMed ID: 23536105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical therapy for smoking cessation].
    Zeller A
    Ther Umsch; 2010 Aug; 67(8):419-25. PubMed ID: 20687045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking cessation-recent advances.
    McNeil JJ; Piccenna L; Ioannides-Demos LL
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):359-67. PubMed ID: 20602163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
    Rose JE; Behm FM
    Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
    Gonzales D; Jorenby DE; Brandon TH; Arteaga C; Lee TC
    Addiction; 2010 Nov; 105(11):2002-13. PubMed ID: 20819082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of combination therapy for smoking cessation.
    Shah SD; Wilken LA; Winkler SR; Lin SJ
    J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of varenicline on attention and inhibitory control among treatment-seeking smokers.
    Rhodes JD; Hawk LW; Ashare RL; Schlienz NJ; Mahoney MC
    Psychopharmacology (Berl); 2012 Sep; 223(2):131-8. PubMed ID: 22526531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting.
    Issa JS; Abe TO; Moura S; Santos PC; Pereira AC
    Nicotine Tob Res; 2013 Jun; 15(6):1146-50. PubMed ID: 23128516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
    Johnson TS
    J Am Acad Nurse Pract; 2010 Oct; 22(10):557-63. PubMed ID: 21040090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment with varenicline and nicotine replacement therapy.
    Ebbert JO; Burke MV; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not smoking, essential for healthy lungs].
    Schunack W
    Pharm Unserer Zeit; 2008; 37(6):494-9. PubMed ID: 18956365
    [No Abstract]   [Full Text] [Related]  

  • 17. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
    Aubin HJ; Bobak A; Britton JR; Oncken C; Billing CB; Gong J; Williams KE; Reeves KR
    Thorax; 2008 Aug; 63(8):717-24. PubMed ID: 18263663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline may reduce negative effect while aiding smoking cessation.
    Hays JT
    Evid Based Med; 2014 Feb; 19(1):23. PubMed ID: 23990527
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
    Tsukahara H; Noda K; Saku K
    Circ J; 2010 Apr; 74(4):771-8. PubMed ID: 20154405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
    Johnson M; Anderson P; Lockhart I
    BMC Fam Pract; 2014 Mar; 15():47. PubMed ID: 24645823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.